Treatment free remission in chronic myeloid leukemia: Lights and shadows

In addition to the best possible overall survival, discontinuation of the tyrosine kinase-inhibitor (TKI) treatment [treatment free remission (TFR)] without observing a recurrence of the disease has become a standard part of chronic myeloid leukemia (CML) care. Worldwide, more than 2000 patients wit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hematol Rep
Hlavní autoři: Molica, Matteo, Noguera, Nelida I., Trawinska, Malgorzata Monika, Martinelli, Giovanni, Cerchione, Claudio, Abruzzese, Elisabetta
Médium: Artigo
Jazyk:Inglês
Vydáno: PAGEPress Publications, Pavia, Italy 2020
Témata:
How to manage - Chronic Myeloid Leukemia
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7520857/
https://ncbi.nlm.nih.gov/pubmed/33042501
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8950
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky